1 / 7

Postmenopausal Osteoporosis Treatment Market Size, Growth Trends, Top Players

The Global Postmenopausal Osteoporosis Treatment Market study focuses major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. It provides information on trends and developments, and focuses on markets and materials, capacities and technologies, and on the changing structure.

energy010
Download Presentation

Postmenopausal Osteoporosis Treatment Market Size, Growth Trends, Top Players

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Postmenopausal Osteoporosis Treatment Market Opportunity, Demand, recent trends, Major Driving Factors and Business Growth Strategies 2032

  2. Industry Insights • Postmenopausal Osteoporosis Treatment Market size is estimated to depict 4.6% CAGR from 2023 to 2032 attributed to the surge in supportive government initiatives and healthcare policies worldwide. • The influx of subsidized healthcare services, medication affordability, and supportive R&D initiatives are creating an environment conducive to effective osteoporosis management. • Additionally, there has been significant increase in government-driven regulations and guidelines for ensuring quality standards and patient safety while promoting the integration of innovative treatment approaches. • Furthermore, the rising efforts by industry players on strengthening their market position through the development of advanced generic formulations and device engineering to enhance patient access to crucial treatment options will augment the industry outlook.

  3. For instance, in November 2023, Teva Pharmaceuticals Inc., a U.S. subsidiary of Teva Pharmaceutical Industries Ltd. received approval to market the generic version of Forteo®1, an injectable containing teriparatide, prescribed to treat osteoporosis in certain male and female patients. • Based on drug type, the market share from the hormone replacement therapy (HRT) segment is anticipated to gain 4.8% CAGR between 2023 and 2032. • HRT has emerged as an effective treatment approach for postmenopausal osteoporosis as it helps to maintain bone density, reduce fracture risk, and manage symptoms. • Additionally, the increasing adoption of hormone replacement therapies to treat postmenopausal women coupled with the ongoing R&D efforts for formulations will propel the segment expansion.

  4. Regional Analysis • Regionally, the Asia Pacific postmenopausal osteoporosis treatment market is set to exhibit 5.2% growth rate through 2032 driven by the aging population and increasing awareness of osteoporosis management. • Competitive Analysis • Amgen Inc. • Theramex (PAI and Carlyle) • Sun Pharmaceutical Industries Ltd. • Pfizer Inc. • Novartis AG • Mylan Inc. (Viatris)

  5. Postmenopausal Osteoporosis Treatment Market @ https://www.gminsights.com/industry-analysis/postmenopausal-osteoporosis-treatment-market Request for sample of this research report @ https://www.gminsights.com/request-sample/detail/7186 Request for customization @ https://www.gminsights.com/roc/7186

  6. Stay In Touch Social Media:

  7. THANK YOU www.gminsights.com

More Related